Evaluate the Efficacy and Safety of Probiotic 6600 as an Adjuvant Therapy for Colitis

NCT07047339 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Colitis
IBD (Inflammatory Bowel Disease)
Probiotic Intervention

Interventions

DRUG: Probiotics 6600
DRUG: Placebo

Sponsor

Changhai Hospital